Genomics pioneer J. Craig Venter dies, reshaped human genome race

J. Craig Venter, the risk-taking biologist who turned the human genome race into a contest between public science and private speed, died on April 29, 2026, in San Diego after a brief hospitalization for unexpected side effects from recently diagnosed cancer. He was 79. The J. Craig Venter Institute said his death closed the life of a scientist who repeatedly pushed biology into new, and often controversial, territory.

Venter’s biggest break came when he founded Celera Genomics and challenged the publicly funded Human Genome Project with faster, privately financed methods. The clash culminated on June 26, 2000, when Celera Genomics and the International Human Genome Sequencing Consortium announced at the White House the first assembly of the human genome and a rough draft. The draft sequence was published in February 2001, and the Human Genome Project was officially completed in April 2003, more than two years ahead of schedule and under budget. The public effort, begun in 1990, had been designed to produce a freely available reference sequence for researchers worldwide, and it involved 20 sequencing centers in six countries in a 13-year international collaboration.

That race was as much about scientific philosophy as it was about data. Francis Collins captured the tension in one line that became emblematic of the era: “The only race we're interested in discussing is the human race.” Venter, by contrast, argued in practice that competition could move science faster than consensus alone. His methods changed how genomics was financed, commercialized and publicized, and they helped set the terms for later battles over who controls foundational biological information.

The accomplishments kept coming. Venter later helped lead one of the first draft sequences of the human genome, then went on to lead the first complete diploid human genome. He also helped build the first synthetic bacterial cell, a milestone that forced scientists, policymakers and the public to confront the promise and risks of redesigning life. In 2010, his team reported a synthetic cell using a synthesized genome inserted into a DNA-free bacterial shell, a feat that drew intense attention from synthetic-biology experts.

Venter’s reach extended far beyond human DNA. His Sorcerer II ocean expedition traveled more than 100,000 kilometers, visited 23 countries and islands across four continents, and produced millions of genes and nearly 1,000 marine microbial genomes. The work expanded the map of life in the oceans even as it underscored a deeper truth about Venter’s career: he accelerated genomics by making science, government and industry compete, and the genome era delivered real tools while also overselling how quickly biology could transform medicine, industry and society.